An anonymous donor has made a $20 million commitment in support of UNC Lineberger Comprehensive Cancer Center and its world-renowned Cellular Immunotherapy Program. A central part of its mission is moving promising discoveries from the laboratory to patients, and the Cellular Immunotherapy Program is helping lead that work. “This gift gets to the heart of our mission of service and reflects the stellar legacy that our experts at UNC Lineberger and within our Cellular Immunotherapy Program have built. Leading this innovative work are Dr. Gianpietro Dotti, director of the UNC Lineberger Cellular Immunotherapy Program and co-leader of the center’s Immunology and Immunotherapy Program; Dr. Natalie Grover, clinical director of the UNC Lineberger Cellular Therapy Program; Dr. Barbara Savoldo, co-director of the UNC Lineberger Immunotherapy Program and director of the UNC Lineberger Advanced Cellular Therapeutic Facility; and Dr. Jonathan S. Serody, director of the UNC Lineberger Cellular Therapy Program, UNC Medical Center. At the forefront of UNC Lineberger’s Cellular Immunotherapy Program is the development and delivery of personalized medicine through clinical research trials.